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Tu es oder tu es nicht, 
aber hör auf es zu versuchen 
                                   Zen-Weisheit 
 
 
 
Je öfter du fragst, 
wie weit du zu gehen hast, 
desto länger scheint die Reise 
                                   aus Australien 
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1 SUMMARY 
1.1 Zusammenfassung 
Die extrazellulare signal-regulierte Kinase Kaskade reguliert Zellprolilferation, 
Differenzierung und Überleben in multizellularen Organismen. Gerüstproteine regulieren 
intrazellulare Signale, indem sie der kritischen räumlichen und zeitlichen Spezifizierung 
dienen. Das Gerüstprotein MEK1- (mitogen-activated protein kinase and ERK kinase 1) 
Partner (MP1) lokalisiert an späten Endosomen mit Hilfe des Adaptorproteins p14. 
Unter Verwendung von sowohl in vitro als auch in vivo Methoden, wurde die 
Auswirkung der Phosphorilierung von p14 auf dessen Interaktion mit MP1 und den Ein-
fluss auf dessen Lokalisierung an späten Endosomen analysiert. Zwei Phosphorilierungs-
Orte wurden auf p14 mittels Massenspektrometrie detektiert. Ein dritter wurde durch 
Analyse mit einem Programm zur Beurteilung möglicher Proteinmodifikationen anhand 
der Proteinsequenz vermutet. p14 und MP1 wurden in Insektenzellen exprimiert und 
aufgereinigt und die Interaktion zwischen diesen beiden Bindungspartnern wurde 
untersucht. Dabei zeigte sich, dass p14 in Insektenzellen phosphoriliert wird. Diese 
Phosphorilierung wirkt sich jedoch nicht auf dessen Interaktion mit MP1 in vitro aus. 
Punktmutanten von p14, die gemeinsam mit MP1 in HeLa Zellen transient 
exprimiert wurden, zeigten keine Veränderung des Lokaliserungsmusters. Immun-
präzipitation mit den enstsprechenden Zelllysaten wies jedoch eine verringernde sowie 
eine verstärkende Wirkung auf die Bindung mit MP1 und den Phosphomutanten, die 
Phosphorilierung vorgeben, T41E und S31E, auf. 
Die in vivo-Funktion dieser Phosphorilierung bleibt vorerst ungeklärt, wenn auch 
diese Ergebnisse unterstützt werden dadurch, dass auch in HeLa Zellextrakten eine 
schwache Doppelbande beobachtet wurde, die möglicherweise diese Modifikation von 
p14 in vivo darstellt. 
Weiters konnte gezeigt werden, dass sowohl p14 als auch MP1 aus Insektenzell-
lysaten in vitro homo-oligomerisieren, was vermutlich auf die sehr ähnliche Topologie 
zurückzuführen ist. 
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1.2 Summary 
 
The extracellular signal-regulated kinase (ERK) cascade regulates proliferation, 
differentiation, and survival in multicellular organisms. Scaffold proteins regulate 
intracellular signaling by providing critical spatial and temporal specificity. The scaffold 
protein MEK1 (mitogen-activated protein kinase and ERK kinase 1) partner (MP1) is 
localized to late endosomes by the adaptor protein p14. 
Using both an in vitro and an in vivo approach, we analyzed the importance of 
phosphorylation of p14 on its interaction with MP1 and the impact on its proper 
localization to endosomes. Two phosphorylation sites on p14 were detected by MS, and a 
third phosphorylation site was predicted by informatic means. Using p14 and MP1 
purified from insect cells, the interaction between the two binding partners was 
investigated showing that phosphorylation on p14 occurs in insect cells, however has no 
impact on its interaction with MP1 in vitro. 
Expressing respective point mutants of p14 in Hela cells did not impact the 
localization pattern of transiently transfected p14 and MP1, nor could a difference in their 
interaction be visualized. However, pulldown assays from these cells showed that two 
phospho-mimicking mutants, T411E and S31E, had an enhancing and inhibitory effect on 
MP1 binding, respectively. 
The function of this phosphorylation remains rather unclear, however, supporting 
our findings, also a faint double band, potentially representing the p14 protein 
modification, was observed in Hela cell extracts. 
Furthermore, p14 as well as MP1 purified from insect cells were shown to be able 
to homo-oligomerize in vitro which may be due to their highly similar structure. 
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2 INTRODUCTION 
 
2.1 Signaling: Measures to obtain temporal and spatial 
specificity 
 
2.1.1 Signaling via cell surface receptors 
 
All cells need to interprete their environment. In order to fulfill this task, 
extracellular information is received and translated accordingly into a specific biological 
response. The extracellular signal needs to be transduced to the cell’s interior to trigger 
appropriate responses. Cell surface receptors are often used to transduce extracellular 
information to the cell. A great variety of ligands, representing the extracellular 
information, bind to and regulate the activity of cell surface receptors. 
Upon ligand binding, receptor signaling is activated. Most activated receptors are 
efficiently cleared from the cell surface by endocytosis and sorted to lysosomes for 
degradation. In contrast, inactive cell surface receptors are constitutively internalized and 
recycled back to the cell surface. Thus, control mechanisms exist that survey the 
internalization and endosomal traffic of cell surface receptors. 
One large family of cell surface receptors is represented by receptor tyrosine 
kinases (RTKs). All of the RTKs are monomers in the plasma membrane, with the 
exception of the insulin receptor. Ligand-induced activation of RTKs stabilizes a receptor 
dimer and results in autophosphorylation of tyrosine residues within the cytoplasmic 
domain of the RTK. The phosphorylated tyrosine residues serve as binding sites for a 
variety of signaling proteins. The recruitment of signaling proteins allows the assembly 
of signaling complexes on the cytoplasmic tail of the activated receptor, connecting 
activated receptors to the respective signal transduction cascades. Stimulation of all 
RTKs triggers the activation of the small G protein Ras. Ras activation is controlled by 
the guanidine exchange factor (GEF). 
A GEF complex is recruited from the cytoplasm to specific phosphotyrosine 
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(pTyr) residues on the activated epidermal growth factor receptor (EGFR). This 
recruitment stimulates Ras activation at the site of the activated EGFR. Activated Ras is 
known to interact with more then 10 different effectors, thereby modulating a multitude 
of downstream signaling cascades. One of them is the highly conserved mitogen-
activated protein kinase (MAPK) signaling or extracellular signal regulated protein 
kinase (ERK) cascade, which is involved in the regulation of cell survival, proliferation 
and differentiation. 
These cascades are highly conserved among eukaryotes and consist of a three-
kinase module that includes a MAPK, which is activated by MAPK/ERK kinase (MEK), 
which itself is activated by a MEK kinase (MEKK) [1]. One of the best characterized 
MAPK cascades consists of MEK1/2, which are Raf isoformes, and ERK1/2, and is 
regulated by Ras.  
By activating Raf, Ras stimulates signaling in the MAPK cascade. Sequential 
phosphorylation events within the cascade transduce signals downstream from Ras to 
effector proteins. Activated Ras binds to and activates Raf (the MAPKKK). Raf 
phosphorylates MEK (the MAPKK) on a critical serine in the activation loop. Next, 
MEK activates ERK (the MAPK) by phosphorylating threonine and tyrosine residues on 
ERK. Activated ERK, in turn, phosphorylates a great variety of targets in the cytoplasm 
and on membranes. In addition, activated ERK rapidly dissociates from MEK and 
translocates to the nucleus to activate transcription factors. 
This pathway is found in non-proliferating cells, but mitogenic signals stimulate it 
and proliferation can be blocked when it is inhibited. Several MAPKs have been 
indentified, demonstrating the existence of several MAPK pathways in metazoans (as 
reviewed in Robinson et al., Curr.Op.Cell Bio 1997 [2]). 
Interestingly, the great number of ligands and their respective cell surface 
receptors use only a limited repertoire of signaling molecules to transduce their 
information, and yet signal transduction mediates a specific biological response. 
Therefore, signaling requires precise spatial and temporal regulation to evoke a unique 
biological response. 
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Biochemical and genetic methods have identified the basic setup of signaling 
cascades, it is however yet not clear how the variety of extracellular cues employs only a 
limited number of signaling cascades to transduce and execute a unique biological 
response. Composition and compartmentalization of signaling complexes, by the use of 
scaffold and adaptor proteins, as well as the duration and amplitude of signaling might be 
crucial to define a specific biological signal. 
 
2.1.2 Specificity via compartmentalization 
 
Signal transduction through the MAPK pathway requires spatial and temporal 
specification. The signaling specificity is regulated by scaffold proteins, which coordinate 
the assembly of MAPK-signaling units [3]. Spatial information is provided by adaptor 
proteins, which define the localization of scaffold complexes [4]. 
Upon EGF stimulation, Ras becomes activated at the plasma membrane. 
However, after endocytosis of the activated EGFR, Ras activity persists on endosomes. 
Furthermore, all components of the Ras-MAPK signaling cascade, namely, Raf, MEK, 
and ERK have been found to reside on endosomes. Internalized EGFRs show all the 
characteristics of receptors that are activated at the plasma membrane. They are bound to 
EGF, exist as dimers, are tyrosine-phosphorylated and interact with the known domains 
of their adaptor proteins to connect receptor activation to downstream effectors. 
All components of downstream signaling cascades have been found to reside not 
only at the plasma membrane but, notably, also on endosomes. It appears likely that 
signaling from the EGFR is not terminated upon internalization. Internalized receptors 
continue to signal until they are sorted to internal vesicles of MVBs. This sorting step 
would disconnect the receptor from its ‘cytoplasmic’ downstream effectors, and signaling 
would be shut off. Cell surface receptors are active at the plasma membrane and in the 
endosomal system. Therefore, activated cell surface receptors could engage a variety of 
different signaling complexes in a sequential manner, first at the plasma membrane, then 
on early endosomes and, finally, on the limiting membrane of MVBs. 
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The activation of diverse signaling complexes by activated receptors along the 
endocytic pathway would increase the signaling potential. Receptor signaling from 
endosomes has been suggested by Teis et al to provide a window of opportunity that 
could contribute to the spatial and temporal regulation of signal transduction. Thus, signal 
transduction could be compartmentalized at the plasma membrane and on endosomes. 
Compartmentalization would provide high flexibility to an otherwise limited number of 
signaling cascades to transduce specific signals from a multitude of signaling cues.  
 
2.1.3 Scaffold and adaptor proteins - introduction of MP1 and p14 
 
Internalized receptors continue to signal until they are sorted to internal vesicles 
of MVBs. This sorting step would disconnect the receptor from its ‘cytoplasmic’ 
downstream effectors, and signaling would be shut off. Activated cell surface receptors 
could engage a variety of different signaling complexes in a sequential manner, first at 
the plasma membrane, then on early endosomes and, finally, on the limiting membrane of 
MVBs (Picture 1) [5]. 
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Picture 1 [5] Endosomal traffic of the activated EGFR. The inactive EGFR localizes in steady-state 
equilibrium to the plasma membrane. It is internalized at low rates and efficiently recycled back via early 
endosomes to the plasma membrane. In contrast, the activated EGFR (yellow arrows) is efficiently 
internalized via CCPs. In the early endosomes they are sorted to the late endosomal/MVB compartment. 
Sorting into the lumen of the MVB shunts the EGFR to the lysosomes, where they are finally degraded. 
The specification of the signaling pathways can be achieved by organizing 
signaling components into multi protein complexes. Scaffold proteins are used to 
organize specific signaling units. Consistently, adaptor proteins, which interact with the 
activated EGFR, have been found to reside together with the cell surface receptor at the 
plasma membrane and also on endosomes. 
Scaffold, anchor and adaptor proteins might bring the spatial distribution and 
activation of specific signaling complexes under the control of activated cell surface 
receptors. The subcellular distribution of scaffolded signaling complexes of one signal 
transduction pathway might finally contribute to the generation of different specific 
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signaling outputs. The formation of such membrane-based scaffold complexes would be 
ideal for the propagation of signals with high spatial as well as temporal resolution and 
specificity within cells [5] Picture 2. 
 
Picture 2. Subcellular compartmentalization of signaling complexes. Different scaffold complexes reside at 
different subcellular compartments. The use of the KSR-scaffold module at the plasma membrane could 
result in the MAPK signaling output A. b-Arrestin 2 (b-Arr 2) assembles another MAPK signaling complex 
on early endosomes and might define MAPK signaling output B. The late endosomal p14/MP1 scaffold 
module generates yet another MAPK signaling complex, which might regulate a MAPK signaling output C. 
Thus, the MAPK pathway might be compartmentalized by a variety of scaffold proteins. This 
compartmentalization of signaling modules might be used to define a specific biological signal. In addition 
to the scaffold modules, other signaling adaptor modules (like the SARA/Smad module) have been found to 
localize on endosomes. [5] 
 
In a yeast-two-hybrid screen for proteins which might be important in regulating 
this signaling cascade but act in a nonenzymatic way, a protein called MP1 (MEK 
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Partner 1) was identified that bound specifically to MEK1 and ERK1 and enhanced their 
activity [1], [6] and [13]. Overexpression of MP1 in cultured cells resulted in an 
enhacement of activation of ERK1, and an increased binding of ERK1 to MEK1, 
suggesting that MP1 functions as an adapter to enhance the efficiency of the MAP kinase 
cascade. 
KSR (kinase suppressor of Ras) and MP1 (MEK1 partner) serve as MAPK-
scaffold proteins to regulate signal transduction in higher eukaryotes. The MAPK-
scaffold protein KSR mediates the interaction between Raf and MEK and is required for 
signal transduction in the Ras-MAPK pathway. MP1 functions as a scaffold protein in the 
Ras MAPK pathway at a different cell compartment. 
MP1 binds specifically to MEK1 and ERK1, thereby facilitating signaling in the 
MAPK cascade. However, unlike KSR, MP1 localizes to late endosomes. The adaptor 
protein p14 is essential to mediate the localization of MP1 to endosomes. The endosomal 
localization of the p14/MP1 complex is exclusively required for the activation of ERK at 
endosomes but not for ERK activation at the plasma membrane. 
By isolating endosomal/lysosomal fractions from EpH4 cells and analyzing the 
membrane-associated fractions, where many known proteins described in regulating 
endocytic transport or scaffolding signal transducing modules are located, Wunderlich et 
al. [7] identified a novel protein of 14 kDa, called p14. Using this protein as bait in a 
yeast-two-hybrid screen, MP1 was found to interact with p14. Furthermore it was found 
that mislocalized p14 (targeted to the plasma membrane) resulted in mislocalization of 
coexpressed MP1, indicating that p14 is required for MP1 localization. The interaction of 
p14 with MP1 suggests that these proteins act as an endosomal adaptor/scaffolding 
complex, which regulates MAPK signaling. 
The existence of adaptor proteins that determine the localization of scaffold 
proteins provides additional flexibility in regulating the efficiency and the specificity of 
the MAPK cascade. As shown by Teis et al. 2006 [8], p14 functions as an endosomal 
adaptor for MP1. p14 is required and sufficient to localize MP1 and the MP1-MAPK-
signaling module to late endosomes, since depletion of p14 resulted in mislocalization of 
Seite 14 von 45 
MP1 to the cytoplasm and in defective ERK signaling. 
Only endosomal ERK activation is affected by short interfering RNA of either 
p14 or MP1 [8]. In contrast, the p14/MP1 complex appears dispensable for the initial 
phase of MAPK signaling at the plasma membrane, which requires KSR. Thus KSR 
assembles a signaling complex at the plasma membrane and generates an ERK signal that 
is different from a p14/MP1-coordinated ERK signal emanating from endosomes. 
However, the molecular mechanisms of compartmentalized ERK signaling remains to be 
elucidated. [9] 
Perturbation of endosomal p14-MP1–MEK1 signaling is detrimental for tissue 
homeostasis, and a mutation in human p14 causes a primary immunodeficiency syndrome 
[8] [10]. These findings support the concept that the endosomal system serves as an 
intracellular site for the regulation of signal transduction [11] [12]. 
A mechanism has been suggested by which a specific signaling unit is generated 
on endosomes to provide specificity as well as spatial and temporal resolution to the ERK 
cascade [13]. An additional means for cells to achieve specificity and increase the 
variation of functions of proteins at the lower level of protein structure are 
posttranslational modifications. 
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2.2 Posttranslational modification (PTM) 
 
2.2.1 General 
 
PTM is the chemical modification of apolypeptide/protein after its translation. It 
is one of the later steps in protein biosynthesis for many proteins. 
During protein synthesis, the 20 different amino acids are incorporated into the 
proteins. After translation, the posttranslational modification of the amino acids extends 
the range of functions of the protein by attaching to it other biochemical functional 
groups such as acetate, phosphate, sulfate, various lipids and carbohydrates, by changing 
the chemical nature of an amino acid (e.g. citrullination) or by making structural changes, 
like the formation of disulfide bridges. 
Also, enzymes may remove amino acids from the amino end of the protein, or cut 
the peptide chain in the middle. For instance, the peptide hormone insulin is cut twice 
after disulfide bonds are formed, and a propeptide is removed from the middle of the 
chain; the resulting protein consists of two polypeptide chains connected by disulfide 
bonds. Picture 1 depicts the genetic code diagram showing the amino acid residues as 
target of modification: 
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Picture 1 
Protein post-translational modification (PTM) is an extremely important cellular 
control mechanism altering the proteins' physical and chemical properties, folding, 
conformation, distribution, stability, activity and consequently, their functions. Examples 
of the biological effects of protein modifications include phosphorylation for signal 
transduction, attachment of fatty acids for membrane anchoring and association, and 
glycosylation for changing protein half-life, targeting substrates, and promoting cell-cell 
and cell-matrix interactions. With the accelerating progress in proteomics, biological 
knowledgebases containing a wealth of information, in particular protein modifications, 
are playing crucial roles in cell regulation research. 
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2.2.2 Phosphorylation 
 
Post-translational phosphorylation is one of the most common protein 
modifications that occurs in animal cells for controlling the behavior of a protein, for 
instance activating or inactivating an enzyme. The vast majority of phosphorylations 
occur as a mechanism to regulate the biological activity of a protein and as such are 
transient. The reversible protein phosphorylation, principally on serine, threonine or 
tyrosine residues, plays critical roles in the regulation of many cellular processes 
including cell cycle, growth, apoptosis and signal transduction pathways. To understand 
the molecular basis of these regulatory mechanisms, it is necessary to identify and 
characterize these phosphorylation sites in proteins. 
The enzymes that phosphorylate proteins are termed kinases and those that 
remove phosphates are termed phosphatases. Protein kinases catalyze reactions of the 
following type: 
 
ATP + protein <----> phosphoprotein + ADP 
 
The largest group of kinases are those that phsophorylate either serines or 
threonines and as such are termed serine/threonine kinases. The ratio of phosphorylation 
of the three different amino acids is approximately 1000/100/1 for 
serine/threonine/tyrosine. (source: wikipedia) 
Although the level of tyrosine phosphorylation is minor, the importance of 
phosphorylation of this amino acid is profound. As an example, the activity of numerous 
growth factor receptors such as the EGF receptor is controlled by tyrosine 
phosphorylation. 
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2.3 Aim of this study 
 
The aim of this study was to establish expression and purification conditions for 
the purification of p14 and MP1 from insect cells using the Baculovirus expression 
system. Furthermore, we aimed in investigating the interaction of p14 and MP1 both in 
vitro by biochemical binding assays and in vivo in Hela cells, and analyze the potential 
involvement of phosphorylation in this interaction and localization of p14 and MP1. 
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3 Materials and Methods 
 
Standard molecular biology techniques were performed as described in Molecular 
Cloning [14]. 
 
3.1 HeLa cell culture  
 
HeLa cells were grown at 37ºC in the presence of 5% CO2 in DMEM 
(Dulbecco’s modified Eagle’s medium) supplemented with 10% FCS, 0.3µg/ml L-
glutamine, 100 units/ml penicillin and 100µg/ml streptomycin. Cells were arrested in 
mitosis by the addition of 100 ng/ml nocodazole for 18 hours and S-phase arrest was 
induced by an 18 hour treatment with 2mM hydroxyurea.  
 
3.2 HeLa cell transfection 
 
Cells were transfected using Lipofectamin Plus Reagent (Invitrogen). 4g of 
DNA were prediluted in 750l medium and mixed with 20l Plus Reagent. The mixture 
was incubated for 15min at room temperature and then combined with 30l of 
Lipofectamin reagent diluted in 750l medium. After an additional incubation for 15min 
the solution was added onto a 10cm dish of Hela cells with 5ml medium (FCS-free). 
After 4h the transfection medium was replaced with normal medium and cells were lysed 
after 48h. 
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3.3 HeLa cell extract preparation  
 
HeLa cells were harvested and centrifuged at 1’200 rpm at 4 ºC for 5 minutes in a 
Heraeus Biofuge. The cell pellet was washed twice with ice cold PBS and resuspended in 
one volume of ice cold extraction buffer (20 mM Tris pH 7.5, 100 mM NaCl, 20 mM β-
glycerophosphate, 5 mM MgCl2, 0.2 % NP-40, 10 % glycerole, 1 mM NaF, 0.5 mM 
DTT and 10µg/ml each of chymostatin, leupeptin and pepstatin A). Cells were broken 
open by dounce homogenization, 20 minutes on ice, and the extract was spun at 20’000 x 
g at 4 ºC for 7 minutes to pellet the DNA. The supernatant was used for 
immunoprecipitation and western blotting (see below). 
 
3.4 Immunoprecipitation 
 
Cell extracts were pre-cleared with Ultralink protein A beads (Pierce). The 
resulting supernatant was subjected to immunoprecipitation using the anti-Xpress or the 
anti-FLAG antibody. Cell extracts were first incubated with the antibody for two hours at 
4°C on a rotating wheel. Then Ultralink A beads were added for 1 hour. Beads were 
washed four times with IP-buffer. 
 
3.5 Protein expression in Sf9 and Hi5 insect cells 
 
Baculoviruses allow high levels of recombinant gene expression in insect cells. 
Commonly used insect cell lines are Sf9, Sf-21, Tn-368 and High-FiveTM BTI-TN-5B1-
4. All four cell lines can be grown as monolayers or in suspension cultures. An advantage 
over protein expression in bacteria is the ability of the insect host to post-translationally 
modify the expressed protein in a manner similar to that of mammalian cells, which in 
many cases is important for the generation of active protein.  
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GST-MP1, His-MP1, GST-p14 and His-p14 Baculoviruses were used for the 
infection of Sf9 cells. Baculoviruses are generated using the BAC-to-BAC expression 
system (Invitrogen, Carlsbad California, USA). The virus was amplified by sequential 
infections of Sf9 cells followed by harvesting the virus containing supernatant after 48h. 
For protein expression, 2 ml virus was used to infect a 175-cm2 filter-capped tissue 
culture flask of 80% confluent monolayer Hi5 cells. 48 hours after infection, cells were 
harvested and washed twice in PBS. A cell pellet from 10 175-cm2 flasks is resuspended 
in 6 ml lysis buffer (50 mM Tris-HCl (pH 7.5), 150 mM KCl, 0.1% TritonX-100, 1 µM 
okadaic acid and 10 µg/ml each of chymostatin, leupeptin and pepstatin A (Sigma-
Aldrich)). After 20 minutes on ice with occasional douncing, the lysates are centrifuged 
for 1 hour at 20,000 x g at 4 °C. This supernatant was then used for the purification of the 
GST- or His-tagged proteins. 
 
3.6 Protein purification from Hi5 insect cells 
 
3.6.1 Affinity Chromatography: 
 
Glutathion S-transferase (GST) fusion proteins can be purified directly from cell 
lysates using Glutathion Sepharose 4B. Employing this affinity chromatography, proteins 
can be eluted under mild, non-denaturating conditions which preserve protein 
antigenicity and functionality. 
Activation: GST Sepharose 4B-beads have to be activated and rid of the 
ethanol which they are stored in by three washing steps in ice cold PBS (10xVol) 
(centrifuge at 700rpm). 
Binding: GST-fusion proteins containing cell lysates were incubated with 
the equivalent volume of GST Sepharose 4B-beads and 1mM DTT for 45min at room 
temperature. The beads were then centrifuged at 700rpm and washed three times with ice 
cold PBS (10xVol). 
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Elution: GST-tagged proteins ere eluted by incubation of the beads with 
elution buffer (20mM Glycerin in Tris/HCl pH 8,2, 1% Triton X-100; final pH: 7,7) for 
30 min at room temperature. 
 
3.6.2 Immobile Metal Affinity Chromatography (IMAC): 
 
The principle of this purification method is based on the reversible interaction 
between various amino acid side chains and immobilized metal ions. To purify His6-
tagged proteins Talon® IMAC resins were used to gain the native protein. 
Activation: The resins are activated by washing with 10xVol of ice cold PBS 
(centrifuge at 700rpm). 
Binding: The insect-cell-lysates were incubated for 45min at room 
temperature with 1xVol of resins. Then the beads were washed three times with 10xVol 
of ice cold IP-buffer and once in cold PBS. 
Elution: His6-fusion proteins were recovered by incubation of the beads 
with elution buffer (50mM NaPi; 300mM NaCl; 150mM Imidazol) for 30min at room 
temperature. 
 
3.7 Interaction Studies 
 
GST-tagged protein was immobilized on Glutathion Sepharose 4B following the 
binding procedure described above, washed three times in cold PBS and then incubated 
for 2h at 4˚C with the putativly interacting protein. After three washing steps in cold IP-
buffer and one in PBS (10xVol each) the proteins were eluted in elution buffer at 4˚C for 
one hour. 
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3.8 Coomassie Staining 
 
The gel was incubated in previously heated up staining solution for 10min and 
then destained. Destain solution was changed several times and and also heated up. 
 
3.9 Silver Staining 
 
Silver staining was performed according to the modified Blum’s protocol: 
The gel was fixed in a solution containing 40% ethanol and 10% acetic acid and 
then washed twice for twenty minutes in 30% ethanol and once for twenty minutes in 
H2O.The gel was then sensitized in 0,02% Na2S2O3 for 1min, washed three times in 
water for 20sec and then incubated in a cold solution of 0,1% AgNO3 for 20min at 4C. It 
was subsequently washed three times in water for 20sec and for another minute after 
changing the gel. The gel was developed in a solution with 3% Na2CO3 and 0,05 
formalin (change solution when developer turns yellow). After the developer has been 
washed away with water for 20sec the staining was terminated by incubation in 5% acetic 
acid. The gel was then washed subsequently in water three times for 10min and stored at 
4˚C in 1% acetic acid. 
 
3.10 In vitro dephosphorylation assay 
 
17 µl  protein solution (ca 2g protein) (or bead volume) 
2,5µl  10x λ-PPase buffer 
2,5µl  20mM MnCl2 
3µl (800U) λ-PPase 
The mixture was incubated at 30ºC for 1h and then washed three times with 
10xVol of ice cold PBS. 
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3.11 In Vitro Kinase assays 
 
For in vitro phosphorylation, GST-p14 was incubated with aPKCζ kinase at 30 ºC 
for 45 minutes in 10 µl buffer containing 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 10 
mM MgCl2, 10 mM β-glycerophosphate, 1 mM EGTA, 1 mM DTT, 1 µM ocadaic acid 
and 0.2 mM cold ATP and 1 µCi/µl γ-[32P]ATP. Phosphorylation was detected by SDS-
PAGE followed by phosphorimaging. 
 
3.12 Immunofluorescence microscopy 
 
24h after transfection cells were split onto cover slips in 6-well dish. After another 
24h, medium was taken off, the cells were washed twice in PBS, fixed with 4% PFA in 
CB for 10min and permeabilise ith 0,25 Triton for 2min. Cells were blocked in IF-
blocking-buffer for 30min and then incubated in prim. antibody (1:500 in IF-blocking-
buffer). After 1h coverslips were washed 5x in WQ-buffer and incubated in sec. antibody 
(1:1000 in blocking-buffer, spin down at 13000rpm for 2min) for 30min. The cells were 
again washed 5x in WQ and then washed once with WQ containing Dapi (1:10000). The 
coverslips were mounted in Moviol, which was dried for 1h at room temperature. 
 
3.13 Reagents 
 
4% PFA:  160mg  PFA 
   2ml  H2O 
   60µl  2N NaOH 
   heat up to 80˚C for 10min 
  add 2ml  2xCB 
 
IF-blocking-buffer: 0,5g  gelatine 
   10ml  H2O (warm up until dissolved) 
   12,5ml 2xCB 
   2,5ml  NH4Cl (0,5M) 
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   1pinch BSA 
 
2xCB pH 6,8:  20mM  PIPES pH6,8 
   300mM NaCl 
   10mM  EGTA 
   10mM  glucose 
   10mM  MgCl2 
 
WQ:   50ml  NH4Cl (0,5M) 
   250ml  2x CB 
   200ml  H2O 
 
Dapi-solution: 1mg/ml DAPI in H2O 
 
Moviol-solution: 5g  MOWIOL 
   20ml  PBS 
   stir over night at 4˚C 
  add 10ml  glycerol 
   centrifuge for 15min at 14000rpm and freeze aliquots at –20˚C 
 
IP-buffer: 50mM  Tris pH 7,5 
  150mM NaCl 
  1%  Triton X-100 
  0,5mM EDTA 
  0,5mM EGTA 
  50mM  NaF 
  5mM  NaPi 
  10%  Glycerol 
   
Protease inhibitors: 10μg/ml aprotinin, 1μg/ml pepstatin, 10μg/ml leupeptin, 1mM 
Pefabloc SC 
 
Phosphatase inhibitors: 2mM Na3Ov4, -Glycerophosphate Disodium Salt, 
Ocadaic Acid 
 
λ-PPase kit (BioLabs) 
λ-PPase buffer: 50mM  Tris-HCl 
   0,1mM  Na2EDTA 
   5mM dithiothreitol 
   0,01% Brij 35 
   (pH 7,5) 
 
Coomassie Brillant Blue R 250 0,24g  Coomassie Brillant Blue R 
     45ml  Methanol Abs. 
     45ml  H2O 
10ml  Acetic Acid 99.5 % 
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     Stear ON 
Store working solution at RT in the dark 
 
Destain solution 150 ml Methanol Abs. 
   70 ml  Acetic Acid 99.5 % 
   780ml  H2O 
 
Amido black  0,5g  Amido Black 
   125ml  Isopropanol 
   50 ml   Acetic Acid 99.5 % 
   325ml  H2O 
keep light protected 
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4 Results 
 
4.1 Purification of p14 from insect cells 
 
To be able to biochemically analyze the function of p14, we aimed to purify this 
protein in high amounts. We chose the insect cell sytem for our protein expression as it is 
known that insect cells, in contrast to E.coli, are able to perform many secondary protein 
modifications, e.g. phosphorylation, which is known to facilitate proper protein folding. 
We used the bac-to-bac baculovirus insect cell system (invitrogen) for the expression of 
p14 and MP1 in Sf9 and Hi5 insect cells. p14 was fused to an N-terminal GST- or His6-
tag and coexpressed with MP1. First I established a purification method to obtain high 
purity and high protein amounts. The GST purification method from Hi5 cell lysates 
resulted in the highest amount and best purity of p14 protein, which efficiently copurified 
MP1 (Figure 1A and data not shown). Therefore we decided to use the GST purification 
method and Hi5 insect cells for further experiments. 
The amount of purified GST-p14 and copurified MP1 was quantified by 
comparison to BSA standard protein on a coomassie SDS-PAGE gel (Fig1B). In the first 
elution step we obtained a protein yield of 1 mg/ml GST-p14 and 0.1 mg/ml MP1, 
whereas in the second elution step only 0.15 mg/ml GST-p14 and less than 0.02 mg/ml 
MP1 were obtained. Also the remaining protein on beads after the elution steps was very 
low, indicating that the first elution step efficiently recovered most of the bound protein.  
In addition to GST-p14 and MP1, four additional bands were detected by silver 
staining. These bands were analyzed by mass spectrometry. In addition to MP1 (5,6) and 
p14 (2), additional proteins GST (4) and a chitinase (3) were identified, the latter most 
likely copurified non-specifically. Interestingly, we found that in addition to the major 
p14 containing band (2) a second band, which showed retarded mobility (1,7), also 
contained p14 protein, indicating that the retarded mobility on a SDS-PAGE might come 
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from secondary modifications of this protein. 
 
 
Figure 1. Purification of p14 from Hi5 insect cells. (A) P14 was N-terminally tagged 
with GST and co-expressed with MP1 in Hi5 insect cells. The protein was isolated on 
GSH sepharose and eluted twice with glutathione. The remaining protein on beads as 
well as both elution steps were analyzed by silver staining. (B) 5 µl of both elution steps 
of (A) were analyzed by SDS-PAGE and coomassie staining and compared to different 
amounts of BSA protein run on the same gel. (C) The samples from (A) were run 
separated by SDS-PAGE followed by silver staining, and bands indicated were excised 
for mass spectrometry analysis, which resulted in the identification of MP1 (5,6), p14 
(1,2,7), GST (4) and a chitinase (3). 
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4.2 Purified p14 is phosphorylated 
 
The identification of a mobility retarded p14 protein from the GST pulldown 
suggested that this protein is subjected to secondary modification in insect cells. To 
analyze if this mobility shift is a result from phosphorylation of GST-p14, the purified 
protein eluates were treated with λPhosphatase (λPPase). Incubation of GST-p14 with 
λPPase resulted in the loss of the mobility shifted band (Figure 2, lane 2), whereas in 
samples which were treated without λPPase (lane 1) or with λPPase and an inhibitor of 
this phosphatase (lane 3) the mobility shifted band was still observed. These results 
strongly suggest that GST-p14 isolated from insect cells is phosphorylated. In addition, 
αp14 western blotting of HeLa cell extracts also showed a second, mobility retarded band 
for p14 (David Teis, personal communication), suggesting that this phosphorylation is 
also present on endogenous p14 in HeLa cells. 
 
 
Figure 2: GST-p14 purified from Hi5 insect cells is phosphorylated. GST-p14 was 
purified from Hi5 insect cells and incubated with (2) and without (1) λPPase, followed by 
SDS-PAGE and αp14 immunoblotting. As a control, one sample was incubated with 
λPPase and a λPPase inhibitor (3). 
 
We then mapped phosphorylation sites on p14 by mass spectrometry. 
Unfortunately we only resulted in a sequence coverage of 40%, because p14 turned out to 
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be very difficult to digest for mass spectrometry analysis. Attempts to purify the 
mobility-shifted p14 in higher amounts by upscaling the purification and concentration of 
the protein failed. However, we still obtained two phosphorylation sites on the sequence 
covered by the mass spectrometry analysis, S31 and T41. We furthermore used 
bioinformatical phosphosite prediction (www.profteispleasehelp.com), which resulted in 
the identification of an additional potential phosphorylation site, T125 (see also Figure 5). 
 
4.3 Phosphorylation of p14 is not required for its interaction 
with MP1 
 
It is known that p14 functions as an adaptor protein, which is required and 
sufficient to localize MP1 to endosomes (Teis et al., 2002). The finding that p14 is 
phosphorylated, opens the possibility that the secondary protein modification of p14 
might be involved in regulating its binding to MP1. Therefore we asked if the interaction 
of p14 with MP1 was dependent on p14’s phosphorylation in vitro. GST-p14 was bound 
to GSH sepharose beads and incubated with or without λPPase. After washing the beads 
to remove the phosphatase, the p14 bound beads were incubated with purified His6-
tagged MP1 (Figure 3). In a second experiment, GST-p14 and MP1 were co-expressed 
and purified with GSH sepharose, followed by λPPase treatment. The amount of bound 
MP1 was analyzed by western blotting. In both cases the amount of MP1 bound to GST-
p14 was not altered after λPPase treatment, suggesting that phosphorylation of p14 is not 
required for its interaction with MP1. 
 
 
Seite 31 von 45 
 
Figure 3: Phosphorylation of p14 is not required for MP1 binding in vitro. GST-p14 
was bound to GSH sepharose beads and subjected to λPPase treatment as described in 
Figure 2. After removal of the phosphatase by washing, the beads were incubated with 
purified His6-MP1 (lanes 2 and 3). As a control, one pulldown was performed from insect 
cells expressing GST alone, and beads were treated as for 2 and 3. GST-p14 and MP1 
were also coexpressed and purified using GSH sepharose, followed by λPPase treatment 
(lanes 4 and 5). The amount of MP1 bound to the GST-p14 pulldown was analyzed by 
immunoblotting. 
 
 
4.4 Characterization of potential p14 phosphorylation sites  
 
As aPKCζ is a serine-/threonine kinase and might be involved in p14 
phosphorylation (and consensus sights for this kinase were found in the sequence of 
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p14???), we tested if this kinase was able to phosphorylate p14 in vitro. GST-p14 was 
incubated with recombinant aPKCζ in the presence of [32P]-ATP and the incorporation 
of radioactive phosphate was analyzed by SDS-PAGE and phosphorimaging. As a 
control, maltose-binding protein (MBP), which is known to be phosphorylated by 
aPKCζ, and GST, which should not be phosphorylated by aPKCζ were used. Figure 4 
shows that both in the presence and absence of MP1, p14 is not phosphorylated by 
aPKCζ, suggesting that another kinase(s) than aPKCζ is responsible for p14 
phosphorylation. 
 
 
 
Figure 4: aPKCζ is not able to phosphorylate p14 in vitro. GST-p14 was purified from 
insect cells and incubated with recombinant aPKCζ in the presence of [32P]-ATP. As a 
positive control the known aPKCζ substrate maltose-binding protein was used. Samples 
were analyzed by SDS-PAGE and phosphorimaging.  
 
Analyzing p14 sequence for the existence of potential kinase consensus sites 
raised our interest for threonine 125 in its C-terminal region. This residue is surrounded 
by a sequence similar to a threonine in Chk2 protein, which is phosphorylated by ATM 
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kinase. We therefore analyzed the ability of this kinase in phosphorylating p14 in vitro. 
However, whereas ATM was able to phosphorylate a control substrate in vitro, p14 was 
not phosphorylated under these conditions (data not shown), suggesting that also this 
kinase is not the p14 phosphorylating kinase. 
As shown in Figure 3, phosphatase treatment of p14 indicates that 
phosphorylation of p14 is not required for its interaction with MP1. However, 
phosphorylation might be important for the subcellular localization of p14 to endosomes. 
We therefore asked if mutation of the potential phosphorylation sites altered localization 
of p14 in the cell. Single mutations of S31, T41 and T125 on p14 to alanine, which 
resembles the non-phosphorylated state, or to glutamate, which resembles the 
phosphorylated state, were performed, as well as the simultaneous mutation of S31 and 
T41 (Figure 5). 
 
 
Figure 5: Mutational analysis of potential phosphorylation sites on p14. (A) The 
serine and threonine residues mutated to alanine (“unphosphorylated”) or glutamate 
(“phosphorylated”) are indicated in colour. S31 and T41 were identified by mass 
spectrometry, whereas T125 was found by phosphosite prediction. (B) S31 and T41 of 
p14 were mutated to alanine or glutamate and transiently expressed as Xpress-tagged 
fusion proteins together with myc-tagged MP1. The localization of these proteins was 
analyzed by αXpress and αmyc staining and fluorescence microscopy. (C) As (B) using 
T125 p14 mutations to alanine or glutamate. 
 
These mutated proteins were transiently expressed as Xpress-tagged fusion 
proteins in HeLa cells together with myc-tagged MP1. The localization of these proteins 
was analyzed by αXpress and αmyc staining and fluorescence microscopy (Figure 6). All 
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p14 mutants showed a tipical endosomal staining, indicating that mutation of the 
potential phosphorylation sites did not influence the localization of p14 . Furthermore, the 
overlay of the staining pattern of Xpress-p14 and myc-MP1 showed that these proteins 
still colocalized, supporting the previous finding that phosphorylation is not required for 
the interaction of these two proteins. In summary, these findings indicate that 
phosphorylation of p14 is not required for the proper subcellular localization of p14 and 
MP1. 
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Figure 6: Interaction between p14-mutants and MP1 in vivo: Hela cells were 
transiently cotransfected with MP1-myc and various Xpress-tagged point-mutants of p14. 
After 24h, the cells were fixed and processed for immunofluorescence using anti-Xpress 
and anti-myc antibodies. The nucleus was visualized with Dapi-staining. 
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 We then asked if phosphorylation of p14 has an influence on the binding to MP1. 
For this reason, we co-expressed MP1-myc and various Xpress-tagged point-mutants of 
p14 in Hela cells, and immunoprecipitated p14 using anti-Xpress antibodies. MP1 bound 
to precipitated p14 was then detected by anti-myc westernblotting. As shown in Figure 7, 
one phospho-mimicing mutant, S31E, showed a strong reduction in MP1 binding, 
whereas another phospho-mimicing mutant, T41E showed an enhanced binding to MP1, 
indicating that these phosphorylation sites might be involved in regulating MP1 binding. 
On the other hand, the double mutant of S31A and T41E reversed the effect to wild type 
levels. 
 
 
 
Figure 7: Analysis of p14 point-mutants for interaction with MP1 in vtiro: Extracts 
from Hela cells that had been transiently cotransfected with myc-MP1 and various Xpress 
p14 mutants were subjected to immunoprecipitation with anti-Xpress antibodies. Input 
and immunoprecipitates were immunoblotted after SDS-PAGE with anti-myc and anti-
p14. 
 
Seite 37 von 45 
4.5 P14 and MP1 form homo-oligomeres in vitro 
 
During these studies, we noticed that in the presence of His6-p14, a GST-p14 
pulldown co-purified the His6-tagged p14. This suggests that p14 forms oligomeres in 
vitro. To investigate this possibility in more detail, we performed pulldown experiments, 
where GST-p14 (4-6) or GST (1-3) as a control were bound to GSH sepharose followed 
by incubation of the beads with insect cell extracts containing His6-p14, His6-MP1 or 
both proteins. The amount of His6-tagged protein bound to GST-p14 was analyzed by 
αhis western blotting. Whereas in a GST control pulldown neither MP1 nor p14 co-
purified (Figure 8A, lanes 1-3), in a GST-p14 pulldown, as expected, His6-MP1 bound 
(lanes 5 and 6), but also some His6-p14 was recovered on the beads in the absence of 
MP1 (lane 4). As GST-p14 is able to co-precipitate His6-p14 also in the absence of MP1, 
these findings strongly indicate that p14 is able to oligomerize in vitro.  
We then asked if also MP1 was able to form homo-oligomeres and performed 
experiments with GST-MP1 and His6-MP1 as described above. As found for p14, also 
GST-MP1 was able to co-purify His6-MP1, indicating that also this protein is able to 
oligomerize in vitro (Figure 8B). 
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Figure 8: P14 and MP1 homo-oligomerize in vitro. (A) GST-p14 was bound to 
sepharose beads and incubated with insect cell lysates containing His6-p14, His6-MP1 or 
both proteins. After extensive washing, the protein bound to the beads was analyzed by 
SDS-PAGE and western blotting. As a control, the incubation was also performed with 
beads bound to GST alone (lanes 1-3). (B) As (A), with the difference that GST-MP1 
was immobilized on the sepharose beads followed by incubation with insect cell lysates 
containing His6-MP1 or His6-MP1 and His6-p14. 
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5 Discussion 
 
Signal transduction through the MAPK pathway requires spatial and temporal 
specification. The signaling specificity is regulated by scaffold proteins, which coordinate 
the assembly of MAPK-signaling units (Catling et al. 2001 and Kolch 2000). Spatial 
information is provided by adaptor proteins, which define the localization of scaffold 
complexes (Pawson and Scott, 1997). p14 acts as an adaptor protein that is required and 
sufficient to localize the MP1-MAPK-signaling module to late endosomes. The late 
endosomal localization of the p14/MP1-MAPK complex is specifically required for 
proper signaling in the ERK cascade (Teis et al., 2002). A further mechanism to provide 
spatial and/or temporal specificity is post translational protein modifications such as 
phosphorylation. This may be applicable to the adaptor protein p14. In this work the 
possible involvement of phosphorylation on p14 in regulating its localization and its 
interaction with MP1 has been analyzed 
 In order to study these proteins, p14 and MP1 were expressed and purified 
from insect cells. Both GST- and His-tagged versions of both proteins were efficiently 
purified. We found that expression in Hi5 cells yielded in higher amounts of protein than 
in Sf9 cell (data not shown), therefore all proteins were expressed in Hi5 insect cells.  
GSTp14 and MP1 were functionally active with respects to their interaction, as 
both the individual purification followed by coincubation, as well as the coexpression of 
the two proteins resulted in their interaction.  
In addition to these two proteins, two impurities were found in the eluates, GST 
and a chitinase, originating from the cell system. Furthermore, another band containing 
GST-p14 was detected by MS, which was retarded in its mobility on SDS-PAGE,. This 
lead to the hypothesis, that this retarded mobility results from secondary modification on 
GST-p14. This band disappeared upon treatment with λPPase, strongly suggesting that 
GST-p14 is phosphorylated. In deed, two phosphorylation sites could be mapped by MS, 
and sequence homology predictions suggested the existence of a third phosphorylation 
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site. 
 Attempts to identify the kinase were taken by identification of potential 
consensus sites on the p14 protein and two different candidate kinases were chosen to 
perform an in vitro radioactive kinase assay: aPKCc, a serine-threonine kinase as well as 
ATM. None of the two kinases could phophorylate GST-p14 purified from the insect 
cells in vitro, indicating that another kinase is responsible for GST-p14 phosphorylation 
in insect cells. 
Both spatial as well as functional impact of this potential phosphorylation were 
targeted for further investigation. Whether the phosphorylation has an impact on the 
interaction of p14 with MP1 was assessed by two approaches. First we investigated the 
importance of p14 phosphorylation for its interaction with MP1 in vitro. The addition of 
λPhosphatase to GST-p14 to both co-purifications of GST-p14 and MP1 as well as to 
immobilized GST-p14 prior to incubation with eluates containing His6-MP1 purified 
from Hi5 insect cells resulted in no difference in the interaction between p14 and MP1, 
indicating that the phosporylation of p14 does not play a role in the interaction between 
the two proteins, at least in vitro. It seems unlikely that the phosphorylation is required 
for the binding of the two proteins in vitro, since only a low amount of the GST-p14 is 
modified and still a strong interaction between the two proteins occurs, regardless of 
phosphatase treatment. For the same reason a positive influence is rather unlikely. It is 
however possible that phosphorylation of p14 partially inhibits the interaction of p14 and 
MP1, which would most likely not be seen in this setup of experiment as the amount of 
modified GST-p14 is very low compared to its unmodified form. 
Therefore we took a second approach where we mutated the phosphorylation sites 
on p14, first to analyze their potential influence on interaction in vivo, as well as to 
analyze the involvement of individual sites on the localization pattern of p14, and on the 
ability of the mutants to colocalize with MP1. 
Visualizing the localization of the p14 mutants in Hela cells via 
immunofluorescence, no change of the localization compared to wt p14 could be 
observed. Also MP1 localized normally to endosomes in these cells. As it has been 
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shown in the mean time that reduction of p14 protein levels by p14 siRNAi causes 
mislocalization of MP1 and that the localization of the MP1-MAPK scaffold complex to 
endosomes is mediated by p14, (Teis et al, 2002) our results suggest that phosphorylation 
of p14 is not required nor inhibitory for its proper localization and interaction with MP1.  
However, pull down assays of p14 mutants revealed that the single point 
mutations S31E and T41E, mimicking phosphorylation, changed the interaction of p14 
with MP1. While the mutant S31E displayed reduced interaction with MP1, the mutant 
T41E lead to an increased interaction between p14 and MP1. This effect was neutralized 
by the immunoprecipiation of MP1-myc with the double point mutant S31E;T41E  
This supports the previous assumption that phophorylation of p14 may have an 
inhibitory effect on its binding capacity of MP1. However, this observation could not be 
confirmed visually, which might be due to the lower sensitivity of fluorescence 
microscopy compared to immunoblotting, where a partial loss of colocalization is 
difficult to be observed under the microscope. However the use of more sensitive 
fluorescence methods as confocal microscopy or real time imaging and quantification 
could address this difference in a more sensitive manner. 
 While there is indication that phosphorylation of p14 can be observed in 
Hela cell extracts (data not shown/David Teis), and we were able to detect two 
phosphorylation sites by MS, the appropriate kinase that targets GST-p14 remains 
unkown. It is furthermore possible that this modification only occurs in insect cells, and 
therefore is not important in vivo. This could be addressed by mapping phosphorylation 
sites on p14 isolated from Hela cells. It is also possible that in addition to the 
phosphorylation sites we found by MS, there are additional sites in the remaining 60% of 
p14 protein not covered in the MS as well as on the GST tag itself, which might be 
responsible for the mobility shift. This could be clarified by analyzing the mobility of p14 
tagged with another tag than GST on SDS-PAGE. Furthermore, in the course of these 
pull down assays and the required additional incubation times, degradation of the proteins 
was observed on the immunoblots through an increased band pattern. Also a faint double 
band could for the first time be detected for the GST protein, which would be in favor of 
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the possibility that additional secondary modification of GST-p14 occurs on the GST-tag. 
Up to these experiments the GST band appeared in quantities, which may have lead to an 
overlay or fusion of the two bands on the immuno blots. It is important to rule out this 
possilibty for instance by repeating the dephosphorylation experiment with λPhosphatase 
on purified GST in quantities and a gel concentration, which allows to separate the two 
bands and distinguish a potential modified form. 
During the investigations p14 as well as MP1 were found to be able to form 
homo-oligomers in vitro when purified in their tagged forms from insect cells using the 
Baculovirus expression system and either a GST-tag or a His6-tag. 
Recently, the crystal structure of the p14-MP1 complex revealed that the overall 
topology of the individual MP1 and p14 proteins is almost identical (Kurzbauer et al, 
2002). It is thus possible that the observed homo-oligomerization of p14 and of MP1 is 
due to the similarity of these proteins and only occurs in vitro. It is therefore unclear if 
this homooligomerization plays a role in vivo. 
 
In summary, we were able to detect phosphorylation on p14 but were not able to 
assign a function to the sites so far, however, this modification needs to be assessed 
deeper for its role in vivo and its potential to provide specificity to the adaptor protein 
p14 in its function in the MAP-kinase signaling pathway. 
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